Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SGC-CLK-1: A chemical probe for the Cdc2-like kinases CLK1, CLK2, and CLK4.
Tiek D, Wells CI, Schröder M, Song X, Alamillo-Ferrer C, Goenka A, Iglesia R, Lu M, Hu B, Kwarcinski F, Sintha P, de Silva C, Hossain MA, Picado A, Zuercher W, Zutshi R, Knapp S, Riggins RB, Cheng SY, Drewry DH. Tiek D, et al. Among authors: riggins rb. Curr Res Chem Biol. 2023;3:100045. doi: 10.1016/j.crchbi.2023.100045. Epub 2023 Sep 22. Curr Res Chem Biol. 2023. PMID: 38009092 Free PMC article.
WNT4 Regulates Cellular Metabolism via Intracellular Activity at the Mitochondria in Breast and Gynecologic Cancers.
Sottnik JL, Shackleford MT, Robinson SK, Villagomez FR, Bahnassy S, Oesterreich S, Hu J, Madak-Erdogan Z, Riggins RB, Corr BR, Cook LS, Treviño LS, Bitler BG, Sikora MJ. Sottnik JL, et al. Among authors: riggins rb. Cancer Res Commun. 2024 Jan 17;4(1):134-151. doi: 10.1158/2767-9764.CRC-23-0275. Cancer Res Commun. 2024. PMID: 38112643 Free PMC article.
Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer.
Olukoya AO, Stires H, Bahnassy S, Persaud S, Guerra Y, Ranjit S, Ma S, Cruz MI, Benitez C, Rozeboom AM, Ceuleers H, Berry DL, Jacobsen BM, Raj GV, Riggins RB. Olukoya AO, et al. Among authors: riggins rb. J Endocr Soc. 2023 Sep 15;7(10):bvad117. doi: 10.1210/jendso/bvad117. eCollection 2023 Aug 28. J Endocr Soc. 2023. PMID: 37766843 Free PMC article.
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer.
Bahnassy S, Stires H, Jin L, Tam S, Mobin D, Balachandran M, Podar M, McCoy MD, Beckman RA, Riggins RB. Bahnassy S, et al. Among authors: riggins rb. bioRxiv [Preprint]. 2023 Aug 22:2023.08.21.554116. doi: 10.1101/2023.08.21.554116. bioRxiv. 2023. PMID: 37662291 Free PMC article. Updated. Preprint.
ROS is a master regulator of in vitro matriptase activation.
Gaymon DO, Barndt R, Stires H, Riggins RB, Johnson MD. Gaymon DO, et al. Among authors: riggins rb. PLoS One. 2023 Jan 30;18(1):e0267492. doi: 10.1371/journal.pone.0267492. eCollection 2023. PLoS One. 2023. PMID: 36716335 Free PMC article.
64 results